SOURCE: BioElectronics Corporation

BioElectronics Corporation

August 10, 2009 10:15 ET

BioElectronics Receives Nationwide CBS News Coverage

Press and Analyst Inquiries Increasing at a Rapid Rate

FREDERICK, MD--(Marketwire - August 10, 2009) - BioElectronics Corp. (PINKSHEETS: BIEL), the maker of inexpensive, disposable drug-free anti-inflammatory devices, today announced that coverage of the Company's message of drug-free pain relief continues to resonate with members of the press and analyst communities resulting in expanding coverage of company. Over the weekend, CBS News broadcasted a nationwide news segment which discussed how ActiPatch™ can be used to treat heel and foot pain.

"The number of press and analyst inquiries we are receiving is impressive," commented Andrew Whelan, CEO at BioElectronics, Corp. "Members of the press and many financial analysts have shown a keen interest in the Tylenol and acetaminophen safety debate and are paying particular attention to drug-free therapies, such as those offered by BioElectronics. Over the next few months our stakeholders should expect to see coverage of the Company continue to accelerate as the FDA takes formal action relative to these issues. We believe we have a revolutionary set of products that will allow us to rewrite pain management and healing over the next few years. It is truly an exciting time for all of us at BioElectronics as we continue our clinical trials and as we prepare additional FDA filings seeking over the counter clearance for our products."

The latest news story can be viewed on the CBS News website at the following link --;cbsnewsLeadStoriesHeadlines

Over the past few weeks there have been numerous other news stories and analyst reports on the Company. We have listed a few of these links below:

About BioElectronics Corporation

BioElectronics Corporation is the maker of ActiPatch® Therapy, RecoveryRx™ Devices, HealFast™ Therapy ( and the Allay™ family of inexpensive, disposable drug-free anti-inflammatory devices. For more information please see

Tylenol is a registered trademark of McNeil pharmaceutical, Inc.

Contact Information

  • For media enquiries, please contact:
    Joe Noel
    (925) 922-2560